505-66-8 | Homopiperazine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$8.00	$5.00
5g	98%	in stock	$10.00	$7.00
10g	98%	in stock	$15.00	$10.00
25g	98%	in stock	$23.00	$16.00

Description

• Catalog Number: AB46250
• Chemical Name: Homopiperazine
• CAS Number: 505-66-8
• Molecular Formula: C5H12N2
• Molecular Weight: 100.1622
• MDL Number: MFCD00006933
• SMILES: C1CNCCNC1

Computed Properties

• Complexity: 39.3
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.5

Literature

• Computational studies of novel chymase inhibitors against cardiovascular and allergic diseases: mechanism and inhibition.

  Chemical biology & drug design 20121201

• Exploration of ring size in a series of cyclic vicinal diamines with σ₁ receptor affinity.

  Bioorganic & medicinal chemistry letters 20120901

• Automated synthesis of a library of triazolated 1,2,5-thiadiazepane 1,1-dioxides via a double aza-Michael strategy.

  ACS combinatorial science 20120813

• Reaction of homopiperazine with endogenous formaldehyde: a carbon hydrogen addition metabolite/product identified in rat urine and blood.

  Drug metabolism and disposition: the biological fate of chemicals 20120801

• Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.

  Pharmacology, biochemistry, and behavior 20120801

• Synthesis and positive inotropic evaluation of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides bearing piperazine and 1,4-diazepane moieties.

  Bioorganic & medicinal chemistry letters 20120701

• 1,4-Ditosyl-1,4-diazepane.

  Acta crystallographica. Section E, Structure reports online 20120601

• Ethyl 2-(7-oxo-3,5-diphenyl-1,4-diaze-pan-2-yl)acetate.

  Acta crystallographica. Section E, Structure reports online 20120401

• Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.

  Bioorganic & medicinal chemistry 20120301

• Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs.

  Journal of medicinal chemistry 20111124

• Methyl (9aR*,10S*,11R*,13aS*,13bS*)-9-oxo-6,7,9,9a,10,11-hexa-hydro-5H,13bH-11,13a-ep-oxy-pyrrolo-[2',1':3,4][1,4]diazepino[2,1-a]isoindole-10-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20111101

• N-substituted homopiperazine barbiturates as gelatinase inhibitors.

  Bioorganic & medicinal chemistry 20110815

• Homopiperazine-1,4-diium bis-[hexa-aqua-cobalt(II)] tris-ulfate.

  Acta crystallographica. Section E, Structure reports online 20110801

• Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parameters.

  Bioorganic & medicinal chemistry letters 20110715

• Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.

  Bioorganic & medicinal chemistry 20110501

• 1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability.

  Bioorganic & medicinal chemistry letters 20110401

• Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄.

  ACS combinatorial science 20110314

• Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.

  Journal of medicinal chemistry 20110310

• Mechanistic insight into the reactivity of oxotransferases by novel asymmetric dioxomolybdenum(VI) model complexes.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20110110

• Lipopolysaccharide-Deficient Brucella Variants Arise Spontaneously during Infection.

  Frontiers in microbiology 20110101

• Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.

  PloS one 20110101

• Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.

  PloS one 20110101

• A series of Cu(II)-azide polymers of Cu6 building units and the role of chelating diamine in controlling their dimensionality: synthesis, structures, and magnetic behavior.

  Inorganic chemistry 20101115

• Bis(homopiperazine-1,4-diium) cyclo-tetra-phosphate-telluric acid (1/2).

  Acta crystallographica. Section E, Structure reports online 20101101

• Synthesis of 2-(4-substituted benzyl-1,4-diazepan-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.

  Bioorganic & medicinal chemistry letters 20100801

• Synthesis of a histamine H(3) receptor antagonist-manipulation of hydroxyproline stereochemistry, desymmetrization of homopiperazine, and nonextractive sodium triacetoxyborohydride reaction workup.

  The Journal of organic chemistry 20100702

• Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.

  Bioorganic & medicinal chemistry letters 20100501

• Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists.

  Bioorganic & medicinal chemistry letters 20100401

• Tertiary skipped diynes: a pluripotent building block for the modular and diversity-oriented synthesis of nitrogen heterocycles.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20100315

• A series of peroxomanganese(III) complexes supported by tetradentate aminopyridyl ligands: detailed spectroscopic and computational studies.

  Journal of the American Chemical Society 20100303

• Dramatic increase of selectivity for heavy lanthanide(III) cations by tuning the flexibility of polydentate chelators.

  Inorganic chemistry 20100118

• Synthesis and evaluation of (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity.

  Bioorganic & medicinal chemistry letters 20091101

• Expedite protocol for construction of chiral regioselectively N-protected monosubstituted piperazine, 1,4-diazepane, and 1,4-diazocane building blocks.

  The Journal of organic chemistry 20090807

• Synthesis of dimeric quinazolin-2-one, 1,4-benzodiazepin-2-one, and isoalloxazine compounds as inhibitors of amyloid peptides association.

  Archiv der Pharmazie 20090801

• Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.

  ChemMedChem 20090701

• Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound.

  Bioorganic & medicinal chemistry letters 20090515

• User-friendly stereoselective one-pot access to 1,4-diazepane derivatives by a cyclodehydrative three-component reaction with 1,3-dicarbonyls.

  Organic & biomolecular chemistry 20090507

• 1,4-Diazepanes derived from (S)-serine--homopiperazines with improved sigma(1) (sigma) receptor affinity and selectivity.

  European journal of medicinal chemistry 20090201

• Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors.

  Bioorganic & medicinal chemistry letters 20081215

• Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.

  Bioorganic & medicinal chemistry 20081115

• Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.

  Bioorganic & medicinal chemistry letters 20070515

• N, N -disubstituted piperazines and homopiperazines: synthesis and affinities at alpha4beta2* and alpha7* neuronal nicotinic acetylcholine receptors.

  Journal of enzyme inhibition and medicinal chemistry 20061201

• Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.

  Journal of medicinal chemistry 20060601

• Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP).

  Farmaco (Societa chimica italiana : 1989) 20050401

• [High throughput screening of pharmacokinetics and metabolism in drug discovery (II)--investigation on in vitro and in vivo correlation in drug metabolism screening].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20050101

• Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives.

  Bioorganic & medicinal chemistry letters 20041101

• Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives.

  Bioorganic & medicinal chemistry 20041015

• Synthesis and biological activity of novel 1,4-diazepane derivatives as factor Xa inhibitor with potent anticoagulant and antithrombotic activity.

  Bioorganic & medicinal chemistry 20040501

• Exploration of composition space in templated uranium sulfates.

  Inorganic chemistry 20031103

• A new class of spermidine-derived alkaloids.

  Organic letters 20030807

• Trypanocidal activity of conformationally restricted pentamidine congeners.

  Journal of medicinal chemistry 20030313

• Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.

  Journal of medicinal chemistry 20020926

• 6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studies.

  Journal of medicinal chemistry 20020829

• New mu-opioid receptor agonists with piperazine moiety.

  Chemical & pharmaceutical bulletin 20011001

• Subtle bite-angle influences on N(2)S(2)Ni complexes.

  Inorganic chemistry 20010702

• Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: comparison with cis-[PtCl2(NH3)2] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20010601